Serum levels of interleukin-6 and Vitamin D at the onset of multiple sclerosis and neuromyelitis optica: A pilot study

Serum levels of interleukin-6 and Vitamin D at the onset of multiple sclerosis and neuromyelitis optica: A pilot study

Background: Interleukin-6 (IL-6) is an important mediator in the acute phase of inflammatory diseases such as neuromyelitis optica (NMO) and multiple sclerosis (MS). The level of IL-6 is higher in cerebrospinal fluid and serum of NMO patients compare to MS. Vitamin D has a regulatory effect on IL-6,...

Full description

Bibliographic Details
Main Authors: Fereshteh Ashtari, Reyhanehsadat Madanian, Sayyed Hamid Zarkesh, Arshia Ghalamkari
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Journal of Research in Medical Sciences
Subjects:
interleukin-6
multiple sclerosis
vitamin d
Online Access:http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2022;volume=27;issue=1;spage=67;epage=67;aulast=Ashtari

Internet

http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2022;volume=27;issue=1;spage=67;epage=67;aulast=Ashtari

Similar Items